Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Capital Expenditures

Arcus Biosciences Inc Capital Expenditures Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Capital Expenditures from 2017 to 2020.
  • Arcus Biosciences Inc Capital Expenditures for the quarter ending March 03, 2020 was $0m a -163.64% increase of 0m year over year
  • Arcus Biosciences Inc Capital Expenditures for the last 12 months ending March 03, 2020 was $-2m a -70.25% increase of 1m year over year
  • Arcus Biosciences Inc Annual Capital Expenditures for 2019 was $-2m a -94.44% increase of 2m from 2018
  • Arcus Biosciences Inc Annual Capital Expenditures for 2018 was $-4m a -47.31% increase of 2m from 2017
  • Arcus Biosciences Inc Annual Capital Expenditures for 2017 was $-6m a 25.66% decrease of -1m from 2016
Other Cash Flow Metrics:
  • Arcus Biosciences Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -86.39% increase of 6m year over year
  • Arcus Biosciences Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-5m
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS Capital Expenditures Data

03/2020$0m
12/2019$0m
09/2019$-1m
06/2019$-1m
03/2019$-1m
12/2018$0m
09/2018$-1m
06/2018$-1m
03/2018$-1m
12/2017$0m

Annual RCUS Capital Expenditures Data

2019$-2m
2018$-4m
2017$-6m
2016$-4m